Actively Recruiting
GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial
Led by Genomic Prediction Inc. · Updated on 2025-08-26
240
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
G
Genomic Prediction Inc.
Lead Sponsor
B
Boston IVF
Collaborating Sponsor
AI-Summary
What this Trial Is About
The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.
CONDITIONS
Official Title
GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women undergoing IVF between 35 and 40 years of age at IVF cycle start
- Use of Intracytoplasmic Sperm Injection (ICSI) or traditional IVF
- Use of ejaculated or testicular sperm
- Use of autologous or donor sperm
- All Controlled Ovarian Hyperstimulation (COH) protocols
You will not qualify if you...
- Use of donor oocytes
- Use of gestational carrier
- Recurrent Pregnancy Loss defined as 3 or more consecutive miscarriages
- Recurrent Implantation Failure defined as 3 or more failed embryo transfers
- Preimplantation genetic testing for monogenic/single gene disorders (PGT-M)
- Being a translocation carrier
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston IVF
Waltham, Massachusetts, United States, 02451
Actively Recruiting
Research Team
T
Talia Metzgar
CONTACT
K
Kristin Rooney
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here